STAT vermutet doch chinesische Förderung ohne allerdings viel Neues auf den Tisch zu bringen
When asked about the funding sources last November, after talking about his clinical trial at the Second International Summit on Human Genome Editing in Hong Kong, He said the work was paid for in part by his own savings and in part by a generous startup fund provided by the university when he was first recruited. Indeed, the university is listed as the funding source on two Chinese-language informed-consent forms provided to STAT, which He used to recruit male and female volunteers, respectively. He may also have been seeking support from another government entity. A source close to the Chinese health ministry told STAT that He’s team had been lobbying the government of the southern province of Hainan to set up IVF clinics specialized in germline editing — changing the DNA of embryos, eggs, or sperm.
Nature mit einem Essay wie es wohl weiter geht und einer Timeline